Category: Dental 
Dental
Dental device maker Align Technology gains 16% on Wall Street, despite missing earnings expectations by a penny with its 1st-quarter earnings.
Shares of Align Technology (NSDQ:ALGN)
rose nearly 16% on Wall Street yesterday after the company reported 1st-quarter sales and earnings growth rates that each hovered around 30%.
The FDA will this month unveil a new medical device post-market surveillance program this month amid increased pressure from doctors following St. Jude Medical's high-profile Riata defibrillator lead recall.
MASSDEVICE ON CALL — Under increasing pressure from doctors, the FDA this month will unveil a new medical device post-market surveillance program aimed at better tracking potentially faulty devices.
The more rigorous program will include unique device identifiers that allow the FDA, doctors and manufacturers to track individual devices and better monitor, track and report defects.
The U.S. International Trade Commission will launch an investigation into Pakistan's ClearCorrect and a U.S. affiliate in response to Align Technology's complaints of patent infringement on orthodontic device preparation technologies.
The U.S. International Trade Commission agreed to launch an investigation into Align Technology's (NSDQ:ALGN) patent infringement claims against overseas competitor ClearCorrect Pakistan and a U.S. affiliate, ClearCorrect Operating.
Tax experts talk timing and tips for preparing for the med-tech tax, Syneron's CE Mark is on hold for its LiteTouch dental laser and Delcath's stock jumps 12% on the 1st commercial sale of ChemoSat.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Biolase Technology CEO Federico Pignatelli touts his $1 annual salary, calling on politicians and other corporate heads to reconsider their own wages, after the release of the company's Wall-Street-meeting 4th quarter earnings; also, Cooper Cos. posts double-digit sales, earnings increases; Delcath slashes 2011 losses; Cantel Medical's Q2 sales, earnings jump more than 20%; Zeltiq's 2011 sales rise 168% as it pares losses by 23%; Lower sales, losses for TranS1 in Q4 & 2011; and Photomedex swings to Q4, 2011 losses.
Biolase Technology (NSDQ:BLTI) CEO Federico Pignatelli agreed to another year at a $1 salary as the dental laser maker met Wall Street's 4th-quarter forecast with a whopping 35% top-line bump.
Pignatelli set his annual pay package at $1 and 35,000 shares of BLTI stock when he took the role of vice chairman in July 2010, a month after he was terminated as president, SEC filings show.
Biolase Technology CEO Federico Pignatelli touts his $1 annual salary, calling on politicians and other corporate heads to reconsider their own wages, after the release of the company's Wall-Street-meeting 4th quarter earnings.
Biolase Technology (NSDQ:BLTI) CEO Federico Pignatelli agreed to another year at a $1 salary as the dental laser maker met Wall Street's 4th-quarter forecast with a whopping 35% top-line bump.
Pignatelli set his annual pay package at $1 and 35,000 shares of BLTI stock when he took the role of vice chairman in July 2010, a month after he was terminated as president, SEC filings show.
Incoming J&J CEO Alex Gorsky has his work cut out for him in restoring faith in the health are giant amid recurring recalls and waning consumer patience.
MASSDEVICE ON CALL — Incoming Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky will have a full plate when he takes the corner office in April.
Amid ongoing recalls and related lawsuits, Gorsky has his work cut out for him in restoring consumer faith in health care giant.
